News & Updates

Tirzepatide and injectable semaglutide deliver similar effectiveness against liver disease progression and major adverse liver outcomes (MALO) among adults with overweight or obesity and type 2 diabetes (T2D), a study has shown.

In the real-world treatment of patients with inflammatory bowel disease (IBD), the use of guselkumab yields high remission rates and has an overall safety profile that mirrors those in randomized controlled trials, according to a large prospective study.

In the treatment of Chinese patients with metabolic dysfunction-associated steatohepatitis (MASH) and F2 or F3 fibrosis, the use of the selective thyroid hormone receptor-β agonist simedeutirom helps improve disease activity without worsening of fibrosis, as shown in a phase IIb trial.

A transcranial ultrasound-based wearable patch device appears to increase rapid eye movement (REM) sleep duration by 4.6 percent while reducing latency by 24 percent, as shown in a study.

In patients with kidney failure who are undergoing haemodialysis, initiating treatment with apixaban soon after a diagnosis of atrial fibrillation (AF) is associated with lower risks of ischaemic stroke and clinically important bleeding compared with warfarin, according to a study.

Having a ChatGPT-based counselling tool in a local specialist HIV and sexual health clinic setting has been shown to be feasible and acceptable to both patients and healthcare professionals (HCPs) in a pilot implementation study from Singapore.